🇺🇸 FDA
Patent

US 7390668

Intracorporeal medicaments for photodynamic treatment of disease

granted A61KA61K31/352A61K41/0038

Quick answer

US patent 7390668 (Intracorporeal medicaments for photodynamic treatment of disease) held by Provectus Pharmatech, Inc. expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Provectus Pharmatech, Inc.
Grant date
Tue Jun 24 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/352, A61K41/0038, A61K41/0057, A61K41/0071